Henry Ford Health

Henry Ford Health Scholarly Commons
Urology Articles
11-1-2022

Perioperative outcomes following robot-assisted partial
nephrectomy in elderly patients
Gopal Sharma
Milap Shah
Puneet Ahluwalia
Prokar Dasgupta
Benjamin J. Challacombe

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.henryford.com/urology_articles

Urology

Authors
Gopal Sharma, Milap Shah, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J. Challacombe, Mahendra
Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M. Buffi, Ananthakrishanan Sivaraman, James R. Porter,
Craig G. Rogers, Alexandre Mottrie, Ronney Abaza, Khoon Ho Rha, Daniel Moon, Thyavihally B. Yuvaraja,
Dipen J. Parekh, Umberto Capitanio, Kris K. Maes, Francesco Porpiglia, Levent Turkeri, and Gagan Gautam

World Journal of Urology (2022) 40:2789–2798
https://doi.org/10.1007/s00345-022-04171-4

ORIGINAL ARTICLE

Perioperative outcomes following robot‑assisted partial nephrectomy
in elderly patients
Gopal Sharma1 · Milap Shah1 · Puneet Ahluwalia1 · Prokar Dasgupta2 · Benjamin J. Challacombe3 ·
Mahendra Bhandari4 · Rajesh Ahlawat5 · Sudhir Rawal6 · Nicolo M. Buffi7 · Ananthakrishanan Sivaraman8 ·
James R. Porter9 · Craig Rogers10 · Alexandre Mottrie11 · Ronney Abaza12 · Khoon Ho Rha13 · Daniel Moon14 ·
Thyavihally B. Yuvaraja15 · Dipen J. Parekh16 · Umberto Capitanio17 · Kris K. Maes18 · Francesco Porpiglia19 ·
Levent Turkeri20 · Gagan Gautam1
Received: 10 May 2022 / Accepted: 23 September 2022 / Published online: 6 October 2022
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022

Abstract
Objective To compare perioperative outcomes following robot-assisted partial nephrectomy (RAPN) in patients with
age ≥ 70 years to age < 70 years.
Methods Using Vattikuti Collective quality initiative (VCQI) database for RAPN we compared perioperative outcomes
following RAPN between the two age groups. Primary outcome of the study was to compare trifecta outcomes between the
two groups. Propensity matching using nearest neighbourhood method was performed with trifecta as primary outcome for
sex, body mass index (BMI), solitary kidney, tumor size and Renal nephrometery score (RNS).
Results Group A (age ≥ 70 years) included 461 patients whereas group B included 1932 patients. Before matching the two
groups were statistically different for RNS and solitary kidney rates. After propensity matching, the two groups were comparable for baselines characteristics such as BMI, tumor size, clinical symptoms, tumor side, face of tumor, solitary kidney and
tumor complexity. Among the perioperative outcome parameters there was no difference between two groups for operative
time, blood loss, intraoperative transfusion, intraoperative complications, need for radical nephrectomy, positive margins
and trifecta rates. Warm ischemia time was significantly longer in the younger age group (18.1 min vs. 16.3 min, p = 0.003).
Perioperative complications were significantly higher in the older age group (11.8% vs. 7.7%, p = 0.041). However, there
was no difference between the two groups for major complications.
Conclusion RAPN in well-selected elderly patients is associated with comparable trifecta outcomes with acceptable perioperative morbidity.
Keywords Robotic · Partial nephrectomy · Elderly · Propensity-matching

Introduction
Partial nephrectomy (PN) as a treatment option for small
localized renal masses has become the standard of care [1].
Utilization rates of partial nephrectomy for renal masses have
increased across all age groups [2, 3]. Superior functional
and comparable oncological outcomes for PN compared to
radical nephrectomy (RN) have translated into increased
adoption of PN [4, 5]. In recent years, there has been a
trend toward increased utilization of partial nephrectomy
* Gagan Gautam
gagangg@gmail.com
Extended author information available on the last page of the article

as a treatment option for managing localized small renal
masses [6, 7]. However, its utilization in the elderly population remains poor [2, 3]. Reasons for this underutilization
could be manifold. There is little doubt about the efficacy of
partial nephrectomy in renal function preservation compared
to RN [8–10]. However, elderly patients are at a significantly
higher risk of death due to competing causes of mortality.
Therefore, they may not extract long-term cardiovascular
benefits from renal function preservation. Thus, the lack of
proven benefits in terms of overall and cancer-specific survival may be one of the deterrents for undergoing PN in the
elderly population [9–12].
Some studies have even reported superior overall survival
due to a decrease in other causes of mortality such as cardiovascular events due to better renal function preservation with
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Table 1  Comparison of baseline
characteristics between the two
age groups (Age ≥ 70 years
and < 70 years)
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Variable

Age ≥ 70 years
(Group A) (n = 461)

Age < 70 years
(Group B) (n = 1932)

p-value

Age (mean ± SD)
Sex
Male
Female
BMI (Kg/m2)
Tumor size (mean ± SD) mm
Charlson comorbidity index
Clinical symptoms
Asymptomatic
Local
Systemic
Single kidney
Tumor side
Right
Left
Face of tumor
Anterior
Posterior
Polar Location of Tumor
Upper
Mid
Lower
Preoperative hemoglobin
Preoperative creatinine
Preoperative eGFR
Renal Nephrometry Score (Mean ± SD)
RENAL complexity grouping
Low
Intermediate
High
Clinical stage
T1a
T1b
T2a
Number of lesions operated
1
2
3
4
6
Surgical access
Retroperitoneal
Transperitoneal
Operative time (Mean ± SD)
Warm ischemia time (Mean ± SD)
Blood loss ml (Median with range)
Intraoperative transfusion
Intraoperative complications
Need for conversion to radical nephrectomy
Perioperative complications

75.01 ± 4.12

53.4 ± 10.68

< 0.0001

307 (66.6%)
154 (33.4%)
28.1 ± 5.25
35.2 ± 15.8
1.7 ± 1.6

1267 (65.6%)
665 (35.4%)
28.6 ± 6.16
34.8 ± 17.04
1.1 ± 1.3

0.680

394 (85.4%)
63 (13.6%)
4 (0.8%)
22 (4.7%)

1610 (83.3%)
296(15.3%)
26 (1.3%)
38 (1.96%)

238 (51.6%)
223 (48.4%)

976 (50.5%)
956 (49.5%)

0.669

257 (55.7%)
204 (44.3%)

1034 (53.5%)
898 (46.5%)

0.388

146 (31.6%)
154 (33.4%)
161 (34.9%)
12.98 ± 1.61
1.08 ± .40
68.4 ± 23.5
6.88 ± 1.75

615 (31.8%)
749 (38.7%)
568 (29.3%)
13.4 ± 1.71
0.94 ± 0.31
83.5 ± 23.2
7.07 ± 1.83

203 (44%)
229 (49.6%)
29 (6.3%)

754 (39%)
977 (50.5%)
201 (10.4%)

0.011

328 (71.1%)
122 (26.4%)
11 (2.3%)

1345 (69.6%)
519 (26.6)
68 (3.5%)

0.450

430 (93.2%)
23 (4.9%)
6 1.3%)
2 (0.4%)
0

1843 (95.3%)
74 (3.8%)
13 (0.6%)
1 (0.05%)
1 (0.05%)

69 (14.9%)
392 (85.1%)
188.7 ± 63.4
16.2 ± 8.7
50 (20–3500)
9 (1.9%)
22 (4.7%)
11 (2.4%)
58(12.5%)

252 (13%)
1680(87%)
190.6 ± 66.7
18.37 ± 9.26
100 (20–2730)
64 (3.3%)
91 (4.7%)
18 (0.9%)
151(7.8%)

0.076
0.711
< 0.0001

0.458
0.001

0.07
< 0.0001
< 0.0001
< 0.0001
0.034

0.098

0.276
0.688
< 0.0001
0.153
0.127
0.955
0.010
0.001
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Variable
Grade I
Grade II
Grade III
Grade IV
Trifecta
Positive margin

Age ≥ 70 years
(Group A) (n = 461)

Age < 70 years
(Group B) (n = 1932)

27 (5.8%)
19 (4.1%)
10(2.1%)
2 (0.4%)
330 (71.5%)
14 (3%)

78 (4%)
33 (1.7%)
31 (1.6%)
9 (0.5%)
1375 (71.1%)
52 (2.7%)

p-value

0.006

0.860
0.684

SD standard deviation, BMI body mass index, eGFR estimated glomerular filtration rate, PCS Pelvicalyceal
system
Bold values are statistically significant i.e. p-value < 0.05

PN [13, 14]. However, this comes at the expense of increased
perioperative complications associated with PN [15–17].
The apprehension of increased complications without any
proven oncological benefit has led to a lower acceptance of
PN for the elderly patient population. Population-based studies have shown lower rates of increased adoption of PN for
elderly patients compared to their younger counterparts [2,
3]. Literature on perioperative outcomes following PN for
the elderly population is limited. Furthermore, non-invasive
treatment options as focal therapy has provided an alternative to PN in frail elderly patients with comorbidities [1].
Few studies have reported outcomes following robotassisted partial nephrectomy (RAPN) in the elderly population [18–20]. These studies have reported acceptable outcomes following RAPN in well-selected elderly patients.
However, none of these studies have compared results with
younger patients. Hence, with this Vattikuti collective quality initiative (VCQI) database study, we aimed to compare
perioperative outcomes between patients aged ≥ 70 years
and < 70 years following RAPN.

between patients over the age of 70 years and those aged
less than 70 years. Subgroup analysis of patients over the
age of 80 years and those aged less than 80 years was also
performed. Trifecta outcome was achieved without any complications, negative surgical margins, and warm ischemia
time ≤ 25 min or zero ischemia [24, 26].

Statistical analysis

Materials and methods

We checked the normality of continuous data using Kolmogorov–Smirnov and Shapiro tests of normality. An independent sample Student’s t test was used if data were normally
distributed. Kruskal–Wallis test was used for non-normally
distributed variables. For categorical variables, chi-square
tests or Fisher’s exact tests were used. Propensity matching
using the nearest neighborhood method was performed with
trifecta as the primary outcome for sex, BMI, solitary kidney, tumor size and RNS. All the statistical tests were twosided and performed with a significance level of p < 0.05.
The statistical tests were double-sided and conducted using
SPSS version 23 (IBM corporation, New York, USA) and
Stata (version 16; StataCorp, College Station, TX, USA). A
p-value performed < 0.05 was used to define significance.

Vattikuti collective quality initiative (VCQI)
database

Results

VCQI is a prospective web-based multi-institutional collaborative database for various robotic surgical procedures
[21–24]. Details of centers contributing to the database is
provided in the supplementary file. Ethics clearance was
obtained from each participating institution prior to data
sharing. Due to the multi-institutional nature of the database, patients without adequate data had to be excluded
from the study. For every patient, demographic, perioperative and postoperative data were collected as detailed
in Table 1. Perioperative complications were graded as
per Clavien–Dindo classification [25]. The primary objective of this study was the comparison of trifecta outcomes

From October 2014 to 2020, the participating centers contributed data of 3,801 patients who underwent RAPN. Of
the 3,801 patients, 2,393 patients with complete data were
included for the final analysis.

Prematching
Group A (age ≥ 70 years) included 461 patients, whereas
group B included 1932 patients. A comparison of two groups
for baseline factors revealed that the two groups were comparable for sex, BMI and clinical tumor size. Mean age in A
group was 75.1 years and 52.8 years (p = 0.000) in group B.
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Table 2  Comparison of
perioperative outcomes
between the two age groups
post matching (Age ≥ 70 years
and < 70 years)
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Variable

Age ≥ 70 years
(Group A) (n = 440)

Age < 70 years
(Group B) (n = 440)

Age (mean ± SD)
Sex
Male
Female
BMI (Kg/m2)
Tumor size (mean ± SD) mm
Charlson comorbidity index
Clinical symptoms
Asymptomatic
Local
Systemic
Single kidney
Tumor side
Right
Left
Face of tumor
Anterior
Posterior
Polar Location of Tumor
Upper
Mid
Lower
Preoperative hemoglobin
Preoperative creatinine
Preoperative eGFR
Renal Nephrometry Score (Mean ± SD)
RENAL complexity grouping
Low
Intermediate
High
Surgical access
Retroperitoneal
Transperitoneal
Warm ischemia time (Mean ± SD)
Blood loss ml (Median with range)
Warm ischemia time (Mean ± SD)
Intraoperative transfusion
Intraoperative complications
Need for conversion to radical nephrectomy
Perioperative complications
Grade I
Grade II
Grade III
Grade IV
Trifecta
Positive margin

75.0 ± 4.1

53.3 ± 10.8

< 0.0001

306 (69.5%)
134 (30.5%)
28.6 ± 5.2
34.9 ± 14.3
1.7 ± 1.6

290 (65.9%)
150 (34.1%)
28.6 ± 6.2
34.1 ± 14.8
1.1 ± 1.3

0.249

376 (85.4%)
60 (13.6%)
4 (0.9%)
13 (2.95%)

361 (82%)
73 (16.5%)
6 (1.5%)
9 (2.04%)

226 (51.3%)
214 (48.6%)

222 (50.4%)
218 (49.6%)

0.590

246 (56%)
194 (44%)

237 (53.8%)
203 (46.2%)

0.542

151 (34.3%)
147 (33.4%)
142 (32.2%)
12.9 ± 1.6
1.07 ± 0.4
68.9 ± 23.5
6.9 ± 1.7

119 (27%)
147 (33.4%)
142 (32.2%)
13.5 ± 1.7
0.95 ± 0.3
83.2 ± 22.1
7.0 ± 1.7

190 (43.1%)
222 (50.5%)
28 (6.4%)
64 (14.5%)
376 (85.5%)
189.4 ± 63.6
16.3 ± 8.5
50 (20–3500)
9 (2%)
19 (4.3%)
9 (2%)
52(11.8%)
24 (5.4%)
17 (3.8%)
9 (2%)
2 (0.4%)
317 (72%)
14 (3.2%)

173 (39.3%)
232 (52.7%)
35 (7.9%)
54 (12.2%)
386 (87.8%)
186.7 ± 68.8
18.1 ± 9.4
100 (20–2730)
18 (4%)
24 (5.4%)
5 (1.1%)
34(7.7%)
18 (4.1%)
9 (2%)
6 (1.3%)
1 (0.2%)
309 (70.2%)
20 (4.5%)

Bold values are statistically significant i.e. p-value < 0.05
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p-value

0.155
0.417
< 0.0001

0.372
0.388

0.026
0.0001
< 0.0001
< 0.0001
0.176

0.408

0.323
0.652
0.003
0.153
0.079
0.434
0.281
0.041
0.324

0.552
0.294
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Table 3  Multivariate analysis for the predictors of the trifecta outcomes
Variable
Age
< 70
≥ 70
Sex
Male
Female
Body mass Index
Tumor size
Preoperative creatinine
Renal nephrometry score

Odds ratio

95% confip value
dence interval

Ref
1.11

(0.88, 1.41)

Ref
1.24
1.01
0.98
0.89
0.88

(1.02, 1.52)
(0.99, 1.02)
(0.97, 0.99)
(0.67, 1.17)
(0.83, 0.93)

0.369

0.032
0.097
< 0.0001
0.405
< 0.0001

Bold values are statistically significant i.e. p-value < 0.05

There was no significant difference between the two groups
for clinical symptoms, side of tumor, face of tumor, polar
location of tumor and number of lesions operated. However,
group A included a significantly higher number of patients
with solitary kidneys (4.7% vs. 1.96%, p = 0.000). The mean
RNS score was higher in group B patients (7.07 vs 6.88,
p = 0.03). Group B also had a significantly higher number
of patients in the ‘high complexity’ stratification of RNS
(10.4% vs. 6.3%). Preoperative hemoglobin (12.98 vs. 13.4,
p = 0.000), and eGFR (68.4 vs. 83.5, p = 0.000) were significantly lower in group A, whereas creatinine was significantly
higher in group A (1.08 vs. 0.94, p = 0.000) (Table 1).
In comparison of operative variables, two groups were
comparable for surgical access (transperitoneal or retroperitoneal), duration of surgery, blood loss, positive margin
intraoperative transfusion and intraoperative complications.
Conversion to radical was significantly higher in the older
age group (2.4% vs. 0.9%, p = 0.010) (Table 1). The postoperative complication rate was significantly higher in group
older age group (12.5% vs. 7.8%, p = 0.001). However, the
rate of major (grade III/IV) complications was similar in the
two groups (2.6% vs. 2%, p = 0.841). Overall, major complications were noted in 52 of the patients. Among the patients
with major complications, organ failure/ need for intensive
care was required in 11 patients. Angioembolization was
needed in 21 patients, 11 patients required Double J stenting
for urine leak and rexploration was needed in 9 patients.The
two groups showed no statistically significant difference for
trifecta (71.5% vs. 71.1%, p = 0.860).

Postmatching
Propensity matching was possible for 440 patients in either
group. After propensity matching, the two groups were comparable for baseline characteristics such as BMI, tumor size,

clinical symptoms, tumor side, face of tumor, solitary kidney
and tumor complexity (Table 2). Among the perioperative
outcome parameters there was no difference between the
two groups for operative time, blood loss, intraoperative
transfusion, intraoperative complications, need for radical
nephrectomy, positive margins and trifecta rates. Warm
ischemia time was significantly longer in the younger age
group (18.1 min vs. 16.3 min, p = 0.003). Perioperative complications were significantly higher in the older age group
(11.8% vs. 7.7%, p = 0.041). However, there was no difference between the two groups for major complications. On
multivariate analysis, gender, tumor size and renal nephrometery score were identified as independent predictors of trifecta (Table 3).Standardized mean differenced and variance
ratios for the continuous covariates postmatching have been
provided in the supplementary table.

Subgroup analysis
Comparison of patients aged more than 80 years (n = 69) and
less than 80 years (n = 2324) showed that the two groups were
comparable for certain baseline characteristics such as tumor
size, sex, clinical symptoms, tumor side, face of tumor, tumor
location, solitary kidney and tumor complexity (Table 4).
There was no difference between the two groups for operative time, blood loss, intraoperative transfusion, intraoperative
complications, need for radical nephrectomy, positive margins
and trifecta rates. Warm ischemia time was significantly longer
in the younger age group (18 min vs. 14.2 min, p = 0.001).
Perioperative complications were significantly higher in the
older age group (16% vs. 8.5%, p = 0.031). However, there was
no difference between the two groups for major complications
(2.9% vs. 2.1%, p = 0.675).

Discussion
In the present study, before matching the two age groups were
comparable in sex, BMI and clinical tumor size. However, the
two groups differed significantly for Charlson comorbidity
index, solitary kidney rates and renal nephrometery scores.
There was no difference in the two groups for operative time,
intraoperative complications, need for blood transfusion and
blood loss. Mean WIT was significantly longer in the younger
age group (18.3 ± 9.26 vs. 16.2 ± 8.7, p = 0.000). Mean WIT
remained longer in the younger age group even after matching. Furthermore, the conversion to radical nephrectomy was
significantly higher in the elderly age group. However, there
was no difference between the two groups for conversion to
radical nephrectomy after matching (2% vs. 1.1%, p = 0.281).
We noted significantly higher complications in group A
(age ≥ 70 years) in the present study (before and after matching). However, this increased predilection was limited to the
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Table 4  Comparison of baseline
characteristics between the two
age groups (Age ≥ 80 years
and < 80 years)
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Variable

Age ≥ 80 years
(Group A) (n = 69)

Age < 80 years
(Group B) (n = 2324)

p-value

Age (mean ± SD)
Sex
Male
Female
BMI (Kg/m2)
Tumor size (mean ± SD) mm
Charlson comorbidity index
Clinical symptoms
Asymptomatic
Local
Systemic
Single kidney
Tumor side
Right
Left
Face of tumor
Anterior
Posterior
Polar Location of Tumor
Upper
Mid
Lower
Preoperative hemoglobin
Preoperative creatinine
Preoperative eGFR
Renal Nephrometry Score
(Mean ± SD)
RENAL complexity grouping
Low
Intermediate
High
Operative time (Mean ± SD)
Warm ischemia time (Mean ± SD)
Blood loss ml (Median with range)
Intraoperative transfusion
Intraoperative complications
Need for conversion to radical nephrectomy
Perioperative complications
Grade I
Grade II
Grade III
Grade IV
Major
Trifecta
Positive margin

82.6 ± 2.1

56.8 ± 12.3

45 (65.2%)
24 (34.8%)
27.0 ± 4.3
37.7 ± 13.7
1.6 ± 1.5

1529 (65.8%)
795 (34.2%)
28.6 ± 6.0
34.8 ± 16.8
1.2 ± 1.4

57 (82.6%)
11 (16%)
1 (1.4%)
1 (1.4%)

1947 (83.8%)
348(15%)
29 (1.2%)
59 (2.5%)

34 (49.2%)
35 (50.7%)

1180 (50.7%)
1144 (49.3%)

0.806

40 (57.9%)
29 (42%)

1251 (53.8%)
1073 (46.2%)

0.496

15 (21.7%)
27 (39.1%)
27 (39.1%)
12.6 ± 1.4
1.1 ± 0.3
64.7 ± 19.9
6.88 ± 1.6

746 (32%)
876 (37.7%)
702 (30.2%)
13.3 ± 1.7
0.97 ± 0.3
81 ± 24
7.0 ± 1.8

30 (43.4%)
33 (47.8%)
6 (8.7%)
174.7 ± 46
14.2 ± 9.9
100 (50–9650)
1 (1.4%)
5 (7.2%)
2 (2.9%)
11(16%)
6 (8.7%)
3 (4.3%)
1(1.4%)
1 (1.4%)
2 (2.9%)
49 (71%)
1 (1.4%)

927 (39.8%)
1173 (50.4%)
224 (9.6%)
190.6 ± 66.5
18.0 ± 9.1
150 (50–1500)
72 (3%)
108 (4.6%)
27 (1.1%)
198(8.5%)
99 (4.2%)
49 (2.1%)
40 (1.7%)
10 (0.4%)
50 (2.1%)
1656 (71.2%)
65 (2.8%)

< 0.0001
0.921
0.030
0.158
0.023

0.963
0.568

0.132
0.001
0.002
< 0.0001
0.483

0.831

0.180
0.001
0.163
0.433
0.316
0.194
0.031
0.165

0.675
0.965
1.00

SD standard deviation, BMI body mass index, eGFR estimated glomerular filtration rate, PCS pelvicalyceal
system
Bold values are statistically significant i.e. p-value < 0.05
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minor complications (grade 1 and 2), with rates of major complications being the same between the two groups. Similar
results were noted when we compared for subgroup analysis
for patients with age greater and lesser than 80 years. Literature
is divided on the complication rates following PN compared
to RN. Some studies have reported similar [27–29] and others have reported increased [15, 17] complications in patients
undergoing PN compared to RN irrespective of the age group.
A similar predicament related to complication rates for PN
compared to RN is noted in studies reporting outcomes specifically in the elderly population. Two studies have reported
(Lowrance et al. [30] and Veccia et al. [12]) significantly
higher complication rates for elderly patients who underwent
PN compared to RN. However, An et al. [10] and Antonelli
et al. [8] reported similar complications between RN and PN
in their patient cohort.
Only a handful of studies have previously reported outcomes of PN in the elderly patient population [12, 18–20].
In their cohort of patients with a median age of 78 years,
Ingels et al. reported rates of blood transfusion, trifecta,
intraoperative complications and major complications of
14.7%, 45%, 9% and 6.2%, respectively [18]. In contrast,
patients above ≥ 70 years in the present study had much
higher trifecta rates (71.5%) with lower perioperative morbidity. However, it is to be pointed out that in the study by
Ingels et al. different surgical modalities (open, laparoscopic
and robotic) were employed and a robotic approach was predictive of lower complication rates [18]. In their cohort of
elderly patients who underwent RAPN, Vartolomei et al.
reported perioperative outcomes similar to the present study
[20]. Authors reported median operative time, blood loss,
warm ischemia time and length of stay of 180 min, 100 ml,
14.5 min, and 5 days respectively. Positive surgical margins,
overall complications and trifecta outcomes were reported
in 1.9%, 15.4% and 71.2% respectively [20]. Similar results
were reported by Bindayi et al. in their study for PN in their
cohort of elderly patients [19]. Veccia et al. compared RAPN
to robotic RN in patients older than 65 years of age [12].
Authors reported positive surgical margin, overall complications, major complications and blood transfusion rates as
6%, 24%, 19% and 6%, respectively, in the RAPN group
[12]. Superior rates of these perioperative outcomes were
noted in the present study. Results of RAPN stated in the
present study for the elderly group compare well for perioperative outcomes of the contemporary RAPN series [31–34].
Our study is not without limitations. First, due to the
study's retrospective nature, the probability of a selection
bias in patient inclusion is high. This is highlighted by the
fact that elderly patients had lower complexity tumors in
general, as compared to the matched cohort of younger
patients. Propensity-matching between the two groups was
performed to make two groups comparable for baseline

2795

factors. Furthermore, of the 3,801 patients, we included
only 2393 patients with complete data in this study. This
could be one of the major limitations of this study. Second,
the VCQI database also lacks surgeon experience or center
caseload data. Lastly, third, there is heterogeneity in surgical
techniques, learning curves, and perioperative management
of patients due to the broader reach of the VCQI database
However, for precisely the same reasons, we believe that our
study is closer to the ‘real world scenario’ of the outcomes
of RAPN in elderly patients and may provide unique insights
regarding the same.

Conclusion
Robot-assisted partial nephrectomy in well-selected elderly
patients may be associated with comparable trifecta outcomes. However, the rates of overall perioperative complications were significantly higher in the elderly patient
population.
Supplementary Information The online version contains supplementary material available at https://d oi.o rg/1 0.1 007/s 00345-0 22-0 4171-4.
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